ArticleFrontiers in pediatrics2025
Surgical management of intraventricular hemorrhage and posthemorrhagic hydrocephalus in premature infants - single center experience.
Article in Frontiers in pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Advances in temporizing treatment strategies and associated complications for posthemorrhagic hydrocephalus in preterm infants.Frontiers in pediatrics · 2026Review
- Feasibility Study on Inflammasome Proteins as Biomarkers in the Cerebrospinal Fluid of Pediatric Patients with Hydrocephalus Due to Intraventricular Hemorrhage.Biomolecules · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Intraventricular hemorrhage (IVH) is a severe complication of prematurity, often leading to posthemorrhagic hydrocephalus (PHH). While advances in neonatal care have reduced the incidence of IVH, managing progressive PHH remains challenging. Surgical interventions are crucial for reducing intracranial pressure and preventing long-term neurodevelopmental deficits. This study presents our single-center experience in the surgical management of IVH and PHH in premature infants, highlighting outcomes associated with different surgical strategies. Methods: This retrospective study was conducted at a tertiary neonatal care center between 2017 and 2023. Premature infants (≤32 weeks of gestation or <1,500 g birth weight) were screened for IVH using cranial ultrasound. IVH was graded using the modified Papile classification. Clinical data, imaging findings, and surgical outcomes were collected. Temporizing measures included ventricular access devices (VAD), ventriculosubgaleal (VSG) shunts, and external ventricular drainage (EVD), with permanent ventriculoperitoneal (VP) shunts used for long-term management. Neurodevelopmental outcomes were evaluated at one-year follow-up. Results: The study included 402 premature infants, of whom 75 (18.7%) were diagnosed with IVH. Among these, 6 infants developed PHH requiring surgical intervention. VAD shunting was the preferred temporizing measure due to lower infection rates, with an average duration of 35 days before conversion to VP shunting in 4 children. At one-year follow-up, 64% of infants demonstrated no significant neurological impairment, while 23.2% had severe complications, including developmental delays or motor deficits. Mortality was 20.1%, primarily in infants with Grade III-IV IVH. Logistic regression analysis identified gestational age, corticosteroid treatment, and inborn status as significant predictors of favorable outcomes. Conclusion: Effective surgical management of PHH in premature infants hinges on timely diagnosis, early intervention, and appropriate selection of temporizing measures. Ventricular access devices (VAD) offer a safe and effective strategy to stabilize infants before permanent shunt placement, minimizing complications and improving long-term outcomes. Close collaboration between neonatologists and neurosurgeons remains essential to optimizing care and reducing morbidity in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.